Saniona signs option agreement with Initiator Pharma

By finanzen
2018.11.08. 08:30
7
(Vote: 1)

PRESS RELEASE

November 8, 2018

Saniona, a leading biotech company within ion-channel research, today announced that it has entered into a 1-year option agreement with Initiator Pharma A/S, where Initiator Pharma obtains the right to acquire the AN788 program under...



finanzen - Saniona signs option agreement with Initiator Pharma
Ältere artikel
Ältere Nachrichten
Idorsia Pharmaceuticals Ltd. / Santhera enters into agreement to acquire option from Idorsia for exclusive sub-license of first-in-class dissociative steroid vamorolone . Processed and transmitted by West Corporation. The issuer is solely...
Santhera-Aktien nach Deal mit Idorsia tief im Minus 
Indiva Enters into Agreement to Acquire License in Denmark and Creates Gateway to European Market 
Painter Bros Launches Exclusive Franchise Program 

Santhera Pharmaceuticals Holding AG / Santhera Enters into Agreement to Acquire Option from Idorsia for Exclusive Sub-License of First-in-class Dissociative Steroid Vamorolon. Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. -- Vamorolone in...
Santhera-Aktien nach Deal mit Idorsia tief im Minus 
Indiva Enters into Agreement to Acquire License in Denmark and Creates Gateway to European Market 
Painter Bros Launches Exclusive Franchise Program 

LUND, Sweden, Nov. 20, 2018 /PRNewswire/ --– BioInvent International AB (OMXS: BINV) announced today that it has signed a manufacturing agreement with an undisclosed U.S. cell therapy company for the production of cGMP compliant material to support their...
Cannmart announces asset purchase agreement with Buds2go.ca 
VERTESS Announces Reliable Medical Supply Recapitalization With Seven Hills Capital 
Manufacturing Indonesia 2018: Bringing Technologies to Drive Industry 4.0 for Successful Economy 

Global pharmaceutical companies, including Novartis and others based in Switzerland, are increasingly turning to artificial intelligence to develop new drugs. But this may not lead to lower prices. In 2013, US start-up Berg was asked by the Department of Defense to help improve the detection of prostate cancer, a disease
Ausblick: Lowes Companies gewährt Anlegern Blick in die Bücher 
BBC presenter Alice Roberts in 'battle' with her mother over campaign against faith schools 

Create Account



Log In Your Account